ShortageWatch

Quinapril/Hydrochlorothiazide Tablet shortage

Currently in Shortage

Quinapril/Hydrochlorothiazide Tablet is currently listed as Currently in Shortage in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category
Cardiovascular
Dosage form
Tablet
Routes
ORAL
Last updated
02/02/2026

Strength variants

  • Not specified

Need sourcing help for Quinapril/Hydrochlorothiazide Tablet?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Reason for shortage

Not specified

Availability: Available

ad slot 300x250

Related shortages in Cardiovascular

Lidocaine Hydrochloride Injection

Currently in Shortage
Category
Cardiovascular
Reason
Not specified
Updated
04/07/2026

Lidocaine Hydrochloride Injection

Currently in Shortage
Category
Cardiovascular
Reason
Not specified
Updated
04/07/2026

Lidocaine Hydrochloride Injection

Currently in Shortage
Category
Cardiovascular
Reason
Not specified
Updated
04/07/2026

Furosemide Injection

Currently in Shortage
Category
Cardiovascular
Reason
Not specified
Updated
04/06/2026

Bumetanide Injection

Currently in Shortage
Category
Cardiovascular
Reason
Demand increase for the drug
Updated
04/06/2026

Bumetanide Injection

Currently in Shortage
Category
Cardiovascular
Reason
Demand increase for the drug
Updated
04/06/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.